Close

Jefferis Remains Positive on Shares of Ardea Biosciences (RDEA) Following 28-Week Extension Data For Lesinurad-Allopurinol Combination May 26, 2011 09:34AM
Jefferies Raises Price Target on Ardea Biosciences (RDEA), Maintains Buy Rating Jan 7, 2011 11:50AM
Jefferies Raises Ardea Biosciences's (RDEA) Price Target to $30, Maintains Rating at Buy Nov 9, 2010 11:40AM
Ardea Biosciences (RDEA) Completes 4.03M Common Offering; Net Proceeds of $77.1M Apr 9, 2010 10:05AM
Ardea Biosciences (RDEA) to Offer 3.5M in Common Stock Apr 6, 2010 08:37AM


Dec 18, 2009 09:32AM Jefferies & Co Initiates/Resumes Coverage on Pharma/Biotechnology Stocks